Vaccines for preventing rotavirus diarrhoea: vaccines in use
about
Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeEnvironmental enteric dysfunction: an overviewOptions for improving effectiveness of rotavirus vaccines in developing countries.Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine responseVaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine: a preliminary report of re-analyses of data from a Cochrane Database Systematic Review.Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol.Commercializing diarrhea vaccines for travelers.Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination.Investigating Potential Modes of Actions of Mimusops kummel Fruit Extract and Solvent Fractions for Their Antidiarrheal Activities in Mice.The dichotomy of pathogens and allergens in vaccination approachesEssential interventions for child health.Essential interventions: implementation strategies and proposed packages of careMolecular epidemiology and genetic evolution of the whole genome of G3P[8] human rotavirus in Wuhan, China, from 2000 through 2013Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania.The UK immunisation schedule: changes to vaccine policy and practice in 2013/14Combination vaccines against diarrheal diseases.Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.Genome-Wide Evolutionary Analyses of G1P[8] Strains Isolated Before and After Rotavirus Vaccine Introduction.Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenicEmergence of Rotavirus G12P[8] in St. Louis During the 2012-2013 Rotavirus SeasonIntroduction of a new Rotavirus vaccine: Initial results of uptake and impact on laboratory confirmed cases in Anglia and Essex, United Kingdom, July 2015.Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants.Further characterisation of rotavirus cores: Ss(+)RNAs can be packaged in vitro but packaging lacks sequence specificity.Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.Survival of HIV-1 vertically infected children.Protein-energy malnutrition alters IgA responses to rotavirus vaccination and infection but does not impair vaccine efficacy in mice.Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country.Resurgence of Rotavirus Genotype G12 in St. Louis During the 2014-2015 Rotavirus Season.Economic evaluation of routine infant rotavirus immunisation program in Japan.Comparative characteristics of the VP7 and VP4 antigenic epitopes of the rotaviruses circulating in Russia (Nizhny Novgorod) and the Rotarix and RotaTeq vaccines.Reply letter and clarifications on behalf of La Rosa and colleagues to Sicilian Public Health Authorities.Immunogenicity of rotavirus vaccine (RotarixTM) in infants with environmental enteric dysfunction.Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management.
P2860
Q27004488-6C6B7599-A263-4CCF-ADA9-263865F8E24CQ28261015-D9252182-D47B-4CCC-85DB-E0301E01B46FQ30241442-205F54F3-C8AE-486F-A994-C492C2E5B5C4Q30299958-7AC4165D-4192-4617-868D-F9FAEEEF97FDQ30382576-76C34B73-E23D-4FC7-9B7F-DE2560108789Q30773449-BC41B1FC-38CD-4C13-A112-19AC0D5B9B75Q30872011-B64E0C40-2E27-4155-BBBE-6694A8803033Q33577945-CE45B30A-552F-465A-8036-0F0DFA0417A1Q33646176-302445DF-CBFD-4570-BF30-19F8422DA756Q33717576-B8ADCBF0-3380-4008-8EFA-994DF102DCBFQ33909251-E1C18E50-D646-4BEF-AE91-F49AB3149A93Q34094308-65A8EEFE-B321-4F37-8642-75A3F3CF12BAQ34094325-951F8AE6-2E23-4616-81C2-A422E9BE625CQ35133868-6E82602E-00AA-4C2A-8DAB-C232408F60DFQ35575773-64130766-93D3-4D7B-B8B7-D11A7A50F668Q35598447-3468DC08-6EC5-4AED-A775-59A425002B29Q35896237-AA5D5568-F17E-4D66-A691-F0B8CE80C8B8Q35941163-8529A851-EE79-4376-BD05-AD153555B1C2Q36166655-F47DC737-0FB7-4E18-B720-B090035854E6Q36245512-8870B526-59B6-49E9-B9C4-C1BA642C1625Q36249319-45E75481-E572-4820-992C-826513498003Q36255811-36DA5D26-D309-4BA2-986B-9DA1C286DAF5Q36377394-09F5937E-F614-4513-853E-D1F9F2AEDB6AQ37130805-709D578A-B9FF-4170-961D-7918DF7C373FQ37134934-4A5F6956-2C40-4579-8D77-0E360A48F675Q37372492-8FC6AB44-92BB-4F88-91D6-984D5E7C0BE9Q37398811-8926B753-E86B-4F65-ACB9-D83AF67EE142Q38501139-9935E003-33F1-4661-846E-8EF293B2CE9DQ38623481-EC8F921F-7C98-4FA7-9C73-D8CDBB650EE9Q38975088-4CCC0A99-9A7D-4CC4-8055-109F8395B4CAQ39205753-13253BDE-9E52-450E-B567-E4709FB5FAD6Q40064259-F9029345-6C59-43E0-96FE-7B8050C1978FQ40405465-F305D5D4-6288-447B-8456-850DC3CCFA76Q40496831-18D6AABD-9F2D-46DC-B942-E0A9A687CDEFQ40973295-64F6DB5B-D72F-414E-A809-D509CA5D8533Q45898657-0A9B735E-6E36-4212-B099-900186F9EDCCQ47251751-D874CB62-C078-460E-A2A1-1372F8E9A411Q47581091-35B36B1B-AC86-4E86-92E9-B0F738CBA17CQ47592721-C1BBDB2D-4D44-40E2-AA79-1A3E4EE3C93AQ47712166-1928ACE7-14B7-4DF7-8F92-BE394D4C9E5B
P2860
Vaccines for preventing rotavirus diarrhoea: vaccines in use
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en-gb
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@nl
type
label
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en-gb
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@nl
prefLabel
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en-gb
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@nl
P2093
P2860
P1476
Vaccines for preventing rotavirus diarrhoea: vaccines in use
@en
P2093
Elad Goldberg
Femi Pitan
Hanna Bergman
Harriet MacLehose
Irit Ben-Aharon
Nigel Cunliffe
Sukrti Nagpal
P2860
P356
10.1002/14651858.CD008521.PUB3
P577
2012-11-14T00:00:00Z